Latest papers

[Retinoprotective therapy of diabetes macular edema in elderly patients].

HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later.

[Complications of intravitreal injections--own experience].

Is there a correlation between diabetes mellitus and central corneal thickness?

[New medical care structures for patients with diabetes in Germany].

[Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target].

Mixed messages on systemic therapies for diabetic retinopathy

The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients.

Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary.

Mechanisms of diabetic nephropathy--old buddies and newcomers part 1.

Effect of systemic medications on onset and progression of diabetic retinopathy.

OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes.

Optic capture in the anterior capsulorhexis during combined cataract and vitreoretinal surgery.

Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8).

Medical case retrieval from a committee of decision trees.

Prevalence of diabetic retinopathy in the United States, 2005-2008.

Screening and managing eye disease in 2010: an Asian perspective.

Impaired function of circulating CD34+ CD45− cells in patients with proliferative diabetic retinopathy

Coagulation profile in diabetes and its association with diabetic microvascular complications.

Application of isoproterenol inhibits diabetic-like changes in the rat retina